Systematic Preformulation Studies and Drug-Excipient Compatibility Evaluation of Abacavir Sulphate for Design of Gastroretentive Floating Drug Delivery System
Keywords:
Abacavir sulphate, preformulation, gastroretentive microspheres, HPMC, drug-excipient compatibility, FTIRAbstract
Background: Gastroretentive floating microspheres offer promising approach for sustained delivery of antiretroviral drugs. Comprehensive preformulation studies are essential for rational formulation development and selection of compatible excipients.
Objective: To conduct systematic preformulation studies of Abacavir sulphate for development of gastroretentive floating microspheres and evaluate drug-excipient compatibility with selected polymers.
Methods: Preformulation studies including organoleptic properties, flow properties (angle of repose, bulk density, tapped density, compressibility index, Hausner ratio), melting point, pH, and solubility were performed as per standard procedures. Drug-excipient compatibility was evaluated by physical observation under accelerated stability conditions (40°C/75%RH and 60°C) and FTIR spectroscopy using HPMC K4M and HPMC K100M polymers.
Results: Abacavir sulphate appeared as off-white odorless powder with melting point 165°C. The drug exhibited poor flow properties with angle of repose 29°28", compressibility index 28.04%, and Hausner ratio 1.34. The aqueous solution showed neutral pH (7.5) and drug was freely soluble in water. Compatibility studies revealed no physical changes after one month storage at accelerated conditions. FTIR analysis showed characteristic peaks at 3463.2, 2958.6, 2849.7, 1660.0, and 1451.6 cm⁻¹. No interaction was observed between drug and polymers as all characteristic peaks were retained in mixture spectrum.
Conclusion: Preformulation studies confirmed suitability of Abacavir sulphate for gastroretentive microsphere development. The drug showed good compatibility with HPMC K4M and K100M polymers, supporting their use in formulation design
Downloads
References
1. M. U. Machale and G. Lakshmana Murthy, “Design, formulation and evaluation of abacavir microspheres,” 2018. [Online]. Available: www.ijpir.com
2. N. Chandarsekaran and M. Balamurugan, “Formulation, Characterization and In-vitro Evaluation of Abacavir Sulphate Loaded Microspheres,” 2013. [Online]. Available: https://rjptonline.org/HTMLPaper.aspx?Journal=Research+Journal+of+Pharmacy+and+Technology%3bPID%3d2013-6-7-19
3. A. A. Birajdar, M. T. Deshmukh, and R. V. Shete, “A Review on Gastro-Retentive Floating Microspheres,” Journal of Drug Delivery and Therapeutics, vol. 11, no. 1-s, pp. 131–138, Feb. 2021, doi: 10.22270/jddt.v11i1-s.4518.
4. [S. Arora, J. Ali, A. Ahuja, R. K. Khar, and S. Baboota, “Floating drug delivery systems: a review,” AAPS PharmSciTech, vol. 11, no. 2, pp. 612–622, 2010.
5. E. V. Blynskaya, S. V. Tishkov, V. P. Vinogradov, K. V. Alekseev, A. I. Marakhova, and A. A. Vetcher, “Polymeric Excipients in the Technology of Floating Drug Delivery Systems,” Dec. 01, 2022, MDPI. doi: 10.3390/pharmaceutics14122779.
6. P. Vukkum, G. R. Deshpande, J. M. Babu, R. Muralikrishna, and P. Jagu, “Stress degradation behavior of abacavir sulfate and development of a suitable stability-indicating uhplc method for the determination of abacavir, its related substances, and degradation products,” Sci. Pharm., vol. 80, no. 4, pp. 903–921, 2012, doi: 10.3797/scipharm.1206-11.
7. P. Patel, V. Patel, D. Patel, C. Shah, and U. Upadhyay, “FORMULATION AND EVALUATION OF MODEL DRUG LOADED FLOATING MICROSPHERES,” Certified Journal │ Parita et al. World Journal of Pharmaceutical Research 1076 World Journal of Pharmaceutical Research SJIF Impact Factor, vol. 10, no. 6, p. 1077, 2021, doi: 10.20959/wjpr20216-20547.
8. J. Y. Mukund, R. Kantilal, and R. N. Sudhakar, “Floating microspheres: a review,” 2012.
9. P. M. Desai, C. V. Liew, and P. W. S. Heng, “Understanding Disintegrant Action by Visualization,” J. Pharm. Sci., vol. 101, no. 6, pp. 2155–2164, Jun. 2012, doi: 10.1002/jps.23119.
10. D. Sharma, M. Singh, D. Kumar, and G. Singh, “Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics,” J. Pharm. (Cairo)., vol. 2014, pp. 1–8, Feb. 2014, doi: 10.1155/2014/808167.
11. H. Patil, R. V. Tiwari, and M. A. Repka, “Recent advancements in mucoadhesive floating drug delivery systems: A mini-review,” J. Drug Deliv. Sci. Technol., vol. 31, pp. 65–71, Feb. 2016, doi: 10.1016/j.jddst.2015.12.002.
12. R. Kumar and A. Philip, “Gastroretentive Dosage Forms for Prolonging Gastric Residence Time,” International Journal of Pharmaceutical Medicine, vol. 21, no. 2, pp. 157–171, 2007, doi: 10.2165/00124363-200721020-00005.
13. R. S. Sanghavi, O. Agrawal, Md. Rageeb, and Md. Usman, “Gastroretentive Drug Delivery System: An Overview,” Res. J. Pharm. Technol., pp. 1343–1347, Mar. 2022, doi: 10.52711/0974-360X.2022.00224.
14. A. M. Agrawal, R. V Manek, W. M. Kolling, and S. H. Neau, “Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapor sorption analysis,” J. Pharm. Sci., vol. 100, no. 5, pp. 2094–2106, 2011.
15. H. Bera, S. Boddupalli, and A. K. Nayak, “Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl,” Carbohydr. Polym., vol. 131, pp. 108–118, 2015.
16. Indian Pharmacopoeia, vol. I. Ghaziabad: Government of India, Ministry of Health and Family Welfare, 2018.
17. D. Shah, Y. Shah, and R. Pradhan, “Development and Evaluation of Controlled-Release Diltiazem HCl Microparticles Using Cross-Linked Poly(Vinyl Alcohol),” Drug Dev. Ind. Pharm., vol. 23, no. 6, pp. 567–574, Jan. 1997, doi: 10.3109/03639049709149821.
18. S. Verma, S. Kumar, R. Gokhale, and D. J. Burgess, “Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripening,” Int. J. Pharm., vol. 406, no. 1–2, pp. 145–152, Mar. 2011, doi: 10.1016/j.ijpharm.2010.12.027.
19. V. V. Kumar, B. D. Gladiola, C. M. Chetty, and R. E. Ugandar, “FORMULATION AND EVALUATION OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM OF ZANAMIVIR USING DIFFERENT POLYMERS,” Journal of Biomedical and Pharmaceutical Research, vol. 8, no. 4, Aug. 2019, doi: 10.32553/jbpr.v8i4.641.
20. R. Garg and G. Gupta, “Preparation and Evaluation of Gastroretentive Floating Tablets of Acyclovir,” Curr. Drug Deliv., vol. 6, no. 5, pp. 437–443, Oct. 2009, doi: 10.2174/156720109789941678.
21. S. S. Bharate, S. B. Bharate, and A. N. Bajaj, “Incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review,” Journal of Excipients and Food Chemicals, vol. 1, no. 3, pp. 3–26, 2010.
22. B. Singh, R. Kumar, and N. Ahuja, “Optimizing Drug Delivery Systems Using Systematic ‘Design of Experiments.’ Part I: Fundamental Aspects,” Crit. Rev. Ther. Drug Carrier Syst., vol. 22, no. 1, pp. 27–105, 2005, doi: 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20.
23. M. Lenkalapally, M. Kethavath, and S. Pilankar, “DESIGN AND CHARACTERIZATION OF GASTRO RETENTIVE FLOATING MICROBALLOONS OF ABACAVIR SULPHATE”, doi: 10.24327/ijcar.2024.3029.1655
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
